Results 111 to 120 of about 146,858 (317)

Trigeminal neuralgia associated with a solitary pontine lesion: clinical and neuroimaging definition of a new syndrome

open access: yesPain, 2019
Patients with trigeminal neuralgia associated with solitary pontine lesion have clinical symptoms of trigeminal neuralgia and a single pontine lesion along the trigeminal nerve pathway. They are refractory to surgical treatment.
Sarasa Tohyama   +7 more
semanticscholar   +1 more source

STRATEGI KOMUNIKASI KOMUNITAS TRIGEMINAL NEURALGIA INDONESIA DALAM MEMBERIKAN INFORMASI DAN MENGEDUKASI MASYARAKAT TENTANG PENYAKIT TRIGEMINAL NEURALGIA [PDF]

open access: yes, 2013
This study aims to identify and describe how the communication strategies used by the Trigeminal Neuralgia Indonesian Community in disseminating information and educating the public about the Trigeminal Neuralgia disease. In this research, researchers
AFIDA , NOOR FAJARINA
core  

Nanoparticle Therapeutics in Clinical Perspective: Classification, Marketed Products, and Regulatory Landscape

open access: yesSmall, EarlyView.
This review presents a detailed overview of clinically approved nanoparticle therapeutics, classifying them by type and discussing their unique advantages in drug delivery. It highlights regulatory challenges across global markets and emphasizes the need for adaptive approval pathways.
Nimeet Desai   +5 more
wiley   +1 more source

Role of Platelet-Rich Plasma as an Adjunct Therapy in Trigeminal Neuralgia- A Novel Follow-Up Study

open access: yesJournal of Indian Academy of Oral Medicine and Radiology
Background: Despite promising theoretical benefits, there is a paucity of clinical evidence supporting the use of PRP in managing Trigeminal Neuralgia. This study aims to investigate the potential benefits and efficacy of PRP in Trigeminal Neuralgia, a ...
Puneeta Vohra   +3 more
doaj   +1 more source

A Review on the Management of Peripheral Neuropathic Pain Following Breast Cancer

open access: yesBreast Cancer: Targets and Therapy, 2023
Francisco Avila, Ricardo Torres-Guzman, Karla Maita, John P Garcia, Gioacchino D De Sario, Sahar Borna, Olivia A Ho, Antonio J Forte Division of Plastic Surgery, Department of Surgery, Mayo Clinic, Jacksonville, FL, USACorrespondence: Antonio J Forte ...
Avila F   +7 more
doaj  

Spasmodic Dysphonia

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Spasmodic dysphonia is a laryngeal dystonia that can present as adductor, abductor, or mixed types, with or without tremor. The etiology is not understood fully. Comprehensive evaluation is required to establish the diagnosis. Treatments include voice therapy, medications, botulinum toxin injection, laryngeal surgery, deep brain stimulation ...
Aaron J. Jaworek, Robert T. Sataloff
wiley   +1 more source

Glossopharyngeal neuralgia as onset of multiple sclerosis. [PDF]

open access: yes, 2009
Glossopharyngeal neuralgia is a painful condition, affecting the ninth cranial nerve, rarely described in the course of multiple sclerosis. Here we describe a case of multiple sclerosis presenting with glossopharyngeal neuralgia.
CARRIERI, PIETRO BIAGIO   +2 more
core   +1 more source

Correlation between nerve atrophy, brain grey matter volume and pain severity in patients with primary trigeminal neuralgia

open access: yesCephalalgia, 2018
Background Recent neuroimaging studies have reported grey matter alterations in primary trigeminal neuralgia patients. However, few studies have focused on quantitative measurements of trigeminal nerves and the interaction between trigeminal nerve volume
Y. Wang   +6 more
semanticscholar   +1 more source

A Phase I, First‐In‐Human Study of CBA‐1205, an Anti‐DLK1 Monoclonal Antibody, in Patients With Advanced Solid Tumors

open access: yesCancer Science, Volume 116, Issue 4, Page 1012-1022, April 2025.
We conducted a Phase I trial of CBA‐1205, a novel monoclonal antibody targeting DLK1, in advanced solid tumors, demonstrating safety and tolerability with no dose‐limiting toxicities. Preliminary efficacy was observed, with six patients achieving stable disease for over 6 months, and sDLK1 was identified as a potential biomarker associated with ...
Yuki Katsuya   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy